Segovia, M., Russo, S., Jeldres, M., Mahmoud, Y. D., Perez, V., Duhalde, M., . . . Hill, M. (2019). Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation. Cancer Cell.
استشهاد بنمط شيكاغوSegovia, Mercedes, et al. "Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers By Unleashing Inflammasome Activation." Cancer Cell 2019.
MLA استشهادSegovia, Mercedes, et al. "Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers By Unleashing Inflammasome Activation." Cancer Cell 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.